Biodesix, Inc.
BDSX
$0.2867
-$0.0132-4.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.11% | 17.67% | 30.82% | 32.66% | 31.37% |
| Total Depreciation and Amortization | 7.64% | 4.83% | -3.74% | -14.30% | -13.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.42% | -18.35% | -36.36% | -27.45% | -37.83% |
| Change in Net Operating Assets | -1,118.90% | -291.69% | -256.27% | -268.77% | -145.75% |
| Cash from Operations | -37.53% | -112.72% | -152.21% | -72.26% | 22.91% |
| Capital Expenditure | 80.16% | 85.91% | 75.42% | 34.61% | -44.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.95% | -46.85% | 0.55% | 6.67% | 13.64% |
| Cash from Investing | 78.86% | 85.08% | 74.80% | 34.31% | -43.54% |
| Total Debt Issued | -- | -- | -66.67% | -66.67% | -77.78% |
| Total Debt Repaid | 10.00% | -4.08% | 99.78% | 99.80% | 99.83% |
| Issuance of Common Stock | 89.74% | 94.99% | 19.64% | 90.48% | -50.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 38.49% | 56.89% | 65.96% | 40.24% | 56.02% |
| Cash from Financing | 58.80% | 78.69% | 50.17% | 146.80% | -45.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 144.34% | 99.77% | 147.88% | 321.99% | -255.78% |